|
Volumn 98, Issue 3, 2001, Pages 892-893
|
Treatment of extensive chronic sclerodermatous graft-versus-host disease with high-dose immunosuppressive therapy and CD34+ autologous stem cell rescue [4]
a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CD34 ANTIGEN;
COLLAGEN;
CORTICOSTEROID;
CYCLOPHOSPHAMIDE;
CYCLOSPORIN;
CYCLOSPORIN A;
CYTOKINE;
ETRETINATE;
GRANULOCYTE COLONY STIMULATING FACTOR;
IMMUNOSUPPRESSIVE AGENT;
LYMPHOCYTE ANTIBODY;
MONOCLONAL ANTIBODY;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
PREDNISONE;
THALIDOMIDE;
ADULT;
AUTOTRANSPLANTATION;
CASE REPORT;
CHRONIC DISEASE;
DETERIORATION;
DISEASE COURSE;
DRUG MEGADOSE;
FOLLOW UP;
GRAFT REJECTION;
GRAFT VERSUS HOST REACTION;
HISTOPATHOLOGY;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
ICHTHYOSIS;
IMMUNOSUPPRESSIVE TREATMENT;
LETTER;
MALE;
PRIORITY JOURNAL;
PUVA;
QUALITY OF LIFE;
RHEUMATOID ARTHRITIS;
SCLERODERMA;
SCLEROSIS;
SKIN BIOPSY;
STEM CELL TRANSPLANTATION;
SYSTEMIC LUPUS ERYTHEMATOSUS;
SYSTEMIC SCLEROSIS;
TREATMENT OUTCOME;
|
EID: 0035437129
PISSN: 00064971
EISSN: None
Source Type: Journal
DOI: 10.1182/blood.V98.3.892 Document Type: Letter |
Times cited : (7)
|
References (9)
|